The Europe human microbiome market is expected to reach US$ 346.67 Mn in 2025 from US$ 72.34 in 2017. The market is estimated to grow with a CAGR of 22.2% from 2018-2025.
The growth of the market is driven by the factors such alarming rise in non-communicable diseases (NCDS), rising efforts in the development of human microbiome based therapies and developments in genomics and sequencing techniques. Whereas, rigorous government regulations for advanced therapies and limited understanding is likely to have a negative impact on the growth of the market in the coming years.
Fecal microbiota transplantation (FMT) has developed as an effective treatment for C. difficile infection (CDI) refractory towards antibiotic therapy. The microbiota have important roles in the function of gastrointestinal tract and other aspects of human physiology, there is also growing interest in studying FMT for other clinical indications. The US Food and Drug Administration (FDA) has classified human stool as a biological agent and determined that its use in fecal microbiota transplantation (FMT) therapy and other research are regulated for the insurance of patient safety. With the use of FMT in the treatment of recurrent Clostridium difficile infection (RCDI), an investigational new drug (IND) permit is not required, but is strongly encouraged and may ultimately be required.
Some of the available data suggests that the use of fecal microbiota for the restoration of intestinal flora may be an effective therapy in the management of refractory C. difficile infection. According to the study, “Fecal Microbiota Transplant in Patients with Recurrent Clostridium Difficile Infection” published in Deutscher Ärzteverlag GmbH in 2016 concluded that FMT is a safe and effective treatment option for rCDI but FMT is available only in few centers in Germany. Thus clinical effectiveness of this therapy poses opportunities for the human microbiome treatment to grow in the European region.
Germany is anticipated to lead the adoptions of Human microbiome across the Europe region through the forecast period. Human microbiome is an emerging field in the country and the developments are being conducted widely in the country. The genome-wide association analysis study carried out in Germany was published in 2016. The study identifies variation in vitamin D receptor and other host factors influence the gut microbiota.
In addition, Germany invests considerably for innovation and development of new technologies and procedures. For instance, in April 2017, the German Science Council, has approved 53 million euros in funding for an Institute of Microbiota and Cancer Research in Tübingen. Thus, considering and analyzing the above mentioned factors, the human microbiome market is likely to grow with a significant growth rate in the coming future.
Rest Of Europe Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By Product
• Probiotics
• Foods
• Prebiotics
• Medical Foods
• Diagnostic Device
• Drugs
• Supplements
EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
• Obesity
• Diabetes
• Autoimmune Disorders
• Cancer
• Mental Disorders
• Others
EUROPE HUMAN MICROBIOME- MARKET SEGMENTATION
By Application
• Therapeutics
• Diagnostics
By Country
• U.S.
• Canada
• Mexico
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Disease, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Europe Human microbiome Market – Key takeaways
PART 3. Europe Human microbiome market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Europe Human Microbiome Market – By Product
3.2.2 Europe Human Microbiome Market – By Disease
3.2.3 Europe Human Microbiome Market – By Application
3.2.4 Europe Human Microbiome Market – By Country
3.3 PEST Analysis
3.3.1 Europe – PEST Analysis
PART 4. Europe HUMAN MICROBIOME market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Alarming Rise In Non-Communicable Diseases (NCDs)
4.1.2 Rising Efforts in the Development of Human Microbiome based Therapies
4.1.3 Developments in Genomics and Sequencing techniques
4.2 Key Market Restraints
4.2.1 Rigorous Government Regulations for Advanced Therapies
4.2.2 Limited Understanding Restricts the Growth of Market
4.3 Key Market Opportunities
4.3.1 Increasing Acceptance of Faecal Microbiota Transplantation
4.4 future Trends
4.4.1 Recent Advances in Human Microbiome Drug Discovery
4.5 Impact analysis
PART 5. Human microbiome market – Europe Analysis
5.1 Europe Human microbiome market Revenue Forecasts and Analysis
5.3 Market positioning
5.4 PERFORMANCE OF KEY PLAYERS
Enterome
Yakult Honsha Co., Ltd.
5.5 expert opinions
PART 6. Europe Human microbiome market Analysis – By Product
6.1 Overview
6.2 EUROPE Human microbiome MARKET, BY product, 2017 & 2025 (%)
6.3 Europe Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
6.4 FOODS Market
6.4.1 Overview
6.4.2 Europe Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 Medical food Market
6.5.1 Overview
6.5.2 Europe Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 probiotics Market
6.6.1 Overview
6.6.2 Europe Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 prebiotics Market
6.7.1 Overview
6.7.2 Europe Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 drugs Market
6.8.1 Overview
6.8.2 Europe Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 DIAGNOSTIC DEVICES Market
6.9.1 Overview
6.9.2 Europe Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.10 SUPPLEMENTS Market
6.10.1 Overview
6.10.2 Europe Supplements Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. Europe human microbiome market Analysis – By disease
7.1 Overview
7.2 EUROPE Human microbiome MARKET, BY disease, 2017 & 2025 (%)
7.3 Europe Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
7.4 diabetes Market
7.4.1 Overview
7.4.2 Europe Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CANCER Market
7.5.1 Overview
7.5.2 Europe Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 AUTOIMMUNE DISORDERS Market
7.6.1 Overview
7.6.2 Europe Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 OBESITY Market
7.7.1 Overview
7.7.2 Europe Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 MENTAL DISORDERS Market
7.8.1 Overview
7.8.2 Europe Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.9 Others Market
7.9.1 Overview
7.9.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. Europe human microbiome market Analysis – By application
8.1 Overview
8.2 EUROPE Human microbiome MARKET, BY application, 2017 & 2025 (%)
8.3 Europe Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
8.4 Diagnostics Market
8.4.1 Overview
8.4.2 Europe Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 therapeutics Market
8.5.1 Overview
8.5.2 Europe Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. Europe Human microbiome market Revenue and Forecasts to 2025
9.1 Overview
9.2 Europe Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.3 Europe Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.4 Europe Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
9.5 Europe Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.6 Europe Human microbiome market Revenue And Forecasts to 2025, By Country (%)
9.7 UK Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 UK Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 UK Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 UK Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 UK Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 Germany Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.8.1 Germany Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 France Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
9.9.1 France Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 France Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 France Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 France Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
PART 10. Human Microbiome Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Human Microbiome Market, 2015-2018
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch & Approvals
10.3.3 Expansion
10.3.4 Patent and license
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Acquisitions
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
PART 11. Human microbiome Market–Key company profiles
11.1 ENTEROME
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MICROBIOME THERAPEUTICS, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Rebiotix Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Yakult Honsha Co., Ltd.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Osel Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 Swot Analysis
11.5.6 Key Developments
11.6 Vedanta Biosciences, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Metabiomics Corporate
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Synthetic Biologics, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DuPont
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BiomX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
TABLE 1. Europe Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. Europe Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 3. Europe Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 4. Europe Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 5. Europe Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 6. Europe Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 7. UK Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 8. UK Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 9. UK Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 10. Germany Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 11. Germany Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 12. Germany Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 13. France Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 14. France Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 15. France Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 16. Recent Product Launches & Approvals in the Human Microbiome Market
TABLE 17. Recent EXPANSIONS in the Human Microbiome Market
TABLE 18. Patent and License Organic Growth Strategies in the Human Microbiome Market
TABLE 19. Recent Acquisitions in the Human Microbiome market
TABLE 20. Recent Partnerships & Collaborations in the Human Microbiome market
TABLE 21. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
TABLE 22. Glossary of Terms, Human microbiome market
LIST OF FIGURES
FIGURE 1. UK Human microbiome market, Revenue (US$ Mn), By country 2018 & 2025
FIGURE 2. Europe human microbiome Market By product, Market Share (%), 2017
FIGURE 3. Europe Human microbiome Market By disease, Market Share (%), 2017
FIGURE 4. Europe Human microbiome Market By application, Market Share (%), 2017
FIGURE 5. Human microbiome market Segmentation
FIGURE 6. Europe PEST Analysis
FIGURE 7. human microbiome market impact analysis of drivers & Restraints
FIGURE 8. Europe Human microbiome market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 9. Europe Human microbiome market, By Product, 2017 & 2025 (%)
FIGURE 10. Europe foods Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 11. Europe Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 12. Europe Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. Europe Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. Europe drugs Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. Europe DIAGNOSTIC DEVICES Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. Europe SUPPLEMENTS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. Europe Human microbiome market By disease, 2017 & 2025 (%)
FIGURE 18. Europe Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. Europe Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 20. Europe Autoimmune Diseases Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Europe Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 22. Europe MENTAL DISORDERS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 24. Europe Human microbiome market By application, 2017 & 2025 (%)
FIGURE 25. Europe diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 26. Europe Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. Europe Human microbiome market REVENUE overview, by Country, 2017 (US$ MN)
FIGURE 28. Europe Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Europe Human microbiome market Revenue And Forecasts to 2025, By Country (%)
FIGURE 30. UK Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 31. Germany Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 32. France Human microbiome market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 33. Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 34. Organic Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 35. Inorganic Growth Strategies in the human microbiome Market, 2015-2018
The List of Companies
- Enterome
- MicroBiome Therapeutics, LLC
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Osel Inc.
- Vedanta Biosciences, Inc.
- Metabiomics Corporate
- Synthetic Biologics, Inc.
- DuPont
- BiomX Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Human Microbiome Market
Feb 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Feb 2019